Anti-Human CD274/PD-L1 Monoclonal Antibody (FITC Conjugated) | DL21666F

Anti-Human CD274/PD-L1 Monoclonal Antibody (FITC Conjugated) | DL21666F | Gentaur UK, US & Europe Distribution

Host: Mouse

Synonyms: B7-H1, PD-L1, Programmed cell death ligand 1, B7 homolog 1, B7-H, B7H1, PDL1, PDCD1L1, PDCD1LG1

Reactivity: Human

Application: FCM

Background: CD274, also known as PD-L1 and B7-H1, is type I transmembrane glycoprotein that serves as a ligand for CD279 (PD-1) . This interaction is believed to regulate the balance between the stimulatory and inhibitory signals needed for responses to microbes and maintenance of self-tolerance. CD274 is involved in the costimulation of T cell proliferation and IL-10 and IFN-γ production in an IL-2-dependent and CD279-independent manner. Conflicting data has shown that CD274 can inhibit T cell proliferation and cytokine production, and alternatively, enhance T cell activation. Other studies suggest that CD274 may signal bidirectionally, raising interesting implications for its expression in a wide variety of cell types, including T and B cells, antigen-presenting cells, and nonhematopoietic cells.

Concentration: N/A

Conjugation: FITC

Buffer: PBS with 0.05% Proclin300, 1% BSA

Clone: 29E.2A3

Isotype: Mouse IgG2b, κ